Foroogh Nejatollahi | Medical Microbiology | Best Researcher Award

Published on by Medical Lab Scientist

Prof. Foroogh Nejatollahi | Medical Microbiology | Best Researcher Award

Professor at Shiraz University of Medical Sciences, Iran

Dr. Foroogh Nejatollahi is a distinguished Iranian-Canadian immunologist renowned for her contributions to cancer immunotherapy and antibody engineering. With over three decades of academic and research experience, she has significantly advanced the field of immunodiagnostics and human recombinant antibodies. Her career spans key professorial roles and impactful publications that have positioned her as a leader in cancer biology and molecular immunology. She is the inventor of patented antibody-based therapeutics and continues to inspire through her groundbreaking work in antibody design for oncology.

profile

scopus

Education

Dr. Nejatollahi began her academic journey with a BSc in Biology from Shiraz University in 1985. Her passion for life sciences led her to complete an MSc in Microbiology at Shiraz University of Medical Sciences in 1990, where she later returned as a faculty member. Her academic excellence culminated in a PhD in Pathological Sciences from the University of Manchester, UK, in 2002. This robust academic foundation underpins her extensive research into human antibodies and immune responses against cancer and infectious diseases.

Experience

Over a rich academic tenure, Dr. Nejatollahi served as a Professor at Shiraz University of Medical Sciences from 2015 until her early retirement in 2022. Her previous roles included Associate Professor (2011–2015) and Assistant Professor (2007–2011). Earlier in her career, she was a tutor in Microbiology and Immunology at Jahrom University of Medical Sciences. Beyond teaching, she has mentored PhD, MSc, and MD students, delivering courses in immunology, molecular biology, vaccine technology, and antibody engineering, shaping the next generation of scientists and clinicians.

Research Interest

Her multidisciplinary research interests encompass immunobiology, immunodiagnostics, pathobiology, infection and immunity, and human recombinant antibodies. A major focus of her work lies in cancer biology, especially in developing antibody-based diagnostic and therapeutic agents. Dr. Nejatollahi’s research is notable for using phage display technology to isolate single-chain variable fragments (scFvs) and targeting specific cancer biomarkers like HER2, HER3, EGFR, and CD146. These contributions have propelled advances in cancer-targeted immunotherapy and personalized medicine.

Awards

Dr. Nejatollahi holds the US Patent No. US10905771B2 for her invention titled “Anti-MUC18 Human Immunotoxin and Applications Thereof,” a remarkable milestone that exemplifies her innovation in therapeutic antibody development. Her scientific excellence has been acknowledged through numerous conference presentations, both internationally and nationally, including in Canada, the UK, Italy, and Iran. She has represented Iran at global events on cancer therapeutics, HIV/AIDS, and antibody technology, marking her presence as a thought leader in immunological science.

Publications

Among her extensive body of work, the following are key publications with high citation relevance:

Nejatollahi F. et al. (2002). “Neutralizing human recombinant antibodies to human cytomegalovirus gB and gH.” FEMS Immunology and Medical Microbiology, 34:237–244. [Cited by 81 articles]

Nejatollahi F. et al. (2012). “Down-regulation of VEGF expression by anti-HER2/neu single chain antibodies.” Medical Oncology, 26:378–383. [Cited by 54 articles]

Nejatollahi F. et al. (2013). “Deregulation of HER2 downstream signaling in breast cancer cells by a cocktail of anti-HER2 scFvs.” Oncology Research, 20(8):333–340. [Cited by 37 articles]

Nejatollahi F. et al. (2013). “Antiproliferative and apoptotic effects of anti-Prostate Stem Cell scFv antibody on prostate cancer cells.” Journal of Oncology, 2013:839831. [Cited by 29 articles]

Nejatollahi F. et al. (2014). “Triple blockade of HER2 by a cocktail of scFv antibodies in breast cancer.” Tumor Biology, 35(8):7887–7895. [Cited by 45 articles]

Mohammadi M., Nejatollahi F. et al. (2016). “In silico analysis of tag polypeptides in scFv antibodies.” Journal of Theoretical Biology, 402:100–106. [Cited by 23 articles]

Nejatollahi F. et al. (2017). “Anti-FZD7 scFv antibody inhibits cell growth in colorectal cancer.” Applied Biochemistry and Biotechnology, 181:379–390. [Cited by 31 articles]

Conclusion

In conclusion, Professor Foroogh Nejatollahi exemplifies the highest standards of academic excellence, research innovation, and clinical relevance. Her multi-faceted contributions to antibody engineering, cancer immunotherapy, and infectious disease diagnostics not only advance scientific frontiers but also hold transformative potential in medicine. Her scholarly impact, patent portfolio, and mentorship legacy make her a distinguished and deserving nominee for the Best Researcher Award. Her career stands as a beacon of dedication to translational research and global scientific collaboration.

Sara Ghanem | Genetics | Best Researcher Award

Published on by Medical Lab Scientist

Assist. Prof. Dr. Sara Ghanem | Genetics | Best Researcher Award

Assistant Professor at National Institute of Oceanography and Fisheries, NIOF, Egypt

Dr. Sara Fathi Ghanem is an Assistant Professor of Genetics, Cell Biology, and Histology at the National Institute of Oceanography and Fisheries (NIOF), Egypt. With a strong foundation in interdisciplinary biosciences, she contributes to several departments including the Genome Unit and Central Laboratories at NIOF. Dr. Ghanem is also a key contributor to academic publishing, serving as Associate Editor for prestigious journals such as Frontiers in Veterinary Science and the International Journal of Oceanography and Aquaculture. She is an active reviewer for Q1 and Q2 journals and maintains a consistent track record of impactful research, holding an H-index of 8 with over 170 citations.

profile

scopus

Education

Dr. Ghanem earned her Ph.D. in Genetics, Cell Biology, and Histology from the Faculty of Science at Alexandria University, Egypt. She has further advanced her knowledge through international training, notably completing a diploma supplement in Intracellular Signaling and Trafficking from Bordeaux 2 Victor Segalen University, France. Additionally, she holds certifications in electron microscopy and genetic engineering, showcasing a deep commitment to continuous scientific learning and specialization.

Experience

Professionally, Dr. Ghanem has held multifaceted roles in academia, research, and science communication. She has been instrumental in teaching undergraduate students across faculties such as Science, Dentistry, and Pharmacy at Alexandria University. Her work also includes contributions as a Scientific Explainer at the Alexandria Aquarium, linking public education with marine biology. Beyond academia, she served as the assistant focal point for the EU Horizon 2020 research development initiative at the Ministry of Scientific Research, reflecting her influence in research policy and innovation strategy. She has supervised PhD students and participated in key scientific events as both presenter and organizer.

Research Interest

Dr. Ghanem’s research spans several intersecting disciplines including genetics, molecular biology, histology, aquaculture, and environmental biotechnology. Her studies focus on marine species health, induced breeding, ecotoxicology, and environmental monitoring. Her passion for integrating cellular and molecular biology tools into ecological and fisheries research has allowed her to examine biological responses to pollutants and assess biodiversity in aquatic systems. Her recent work on ultrafiltration membranes for wastewater treatment and trace metal accumulation in fish highlights her commitment to addressing real-world environmental challenges through science.

Award

Dr. Ghanem’s contributions have earned her various recognitions. She received a Certificate of Merit from Bibliotheca Alexandrina and was selected by Egypt’s Ministry of Higher Education and Scientific Research to represent the country in the European CST Med4 Seminar in France. She has also been acknowledged for her outstanding performance in genetic engineering and biotechnology training, and in multiple international conference roles. These honors reflect her dual impact as both a research innovator and a scientific ambassador.

Publication

Among her 34 publications, the following seven demonstrate both academic excellence and global impact:

Ghanem, S.F., et al. (2024). Iron Biofortification in Meat and Poultry Products, Springer US – cited by 9 articles.

Helal, M., Ghanem, S.F. & El-Sikaily, A. (2022). Impact of PCBs, Furan and Dioxin on Hepatocarcinogenesis, IntechOpen – cited by 6 articles.

Ghanem, S.F. (2021). Assessment of Heavy Metals in Nile Tilapia, Aquaculture Reports – cited by 15 articles.

Ghanem, S.F. (2020). Biomarker Analysis for Ecotoxicological Assessment, BMC Veterinary Research – cited by 11 articles.

Ghanem, S.F. (2019). Histological Effects of Pollution on Fish Ovaries, Fish Physiology and Biochemistry – cited by 10 articles.

Ghanem, S.F. (2018). Molecular Markers in Sex Determination of Fish, Aquaculture International – cited by 12 articles.

Ghanem, S.F. (2017). Nutritional Impacts on Aquatic Larvae, Marine Biotechnology – cited by 8 articles.
These works are widely recognized and published in Scopus and SCI-indexed journals.

Conclusion

Dr. Sara Ghanem exemplifies the ideals of a dedicated and impactful researcher. Her interdisciplinary contributions, high publication record, international collaboration, and active mentorship of future scientists mark her as a leader in her field. Her research continues to bridge the gap between environmental sciences and applied biotechnology. Given her demonstrated excellence in academic and applied research, she is a highly deserving candidate for the Best Researcher Award.

Hui-ting Xu | biophysical chemistry | Best Researcher Award

Published on by Medical Lab Scientist

Dr. Hui-ting Xu | biophysical chemistry | Best Researcher Award

lecturer at Yancheng Teachers University, China

Dr. Hui-ting Xu, currently serving as a lecturer at Yancheng Teachers University, is an emerging scholar in the field of biophysics and molecular simulation. Born in 1997, she earned her Ph.D. from Beijing Normal University in 2023, demonstrating early promise in theoretical and computational research. Since joining academia, she has quickly established herself through her work on DNA conformational transitions, ion-specific interactions, and biophysical modeling. Her contributions are already being recognized across peer-reviewed publications, reflecting a strong trajectory in cutting-edge scientific inquiry.

profile

orcid

Education

Dr. Xu completed her doctoral studies in biophysics at Beijing Normal University in 2023, where she focused on advanced theoretical calculations and molecular dynamics simulations. Her education was rooted in computational modeling, allowing her to gain expertise in the analysis of DNA behavior under various ionic and environmental conditions. This rigorous academic training laid a solid foundation for her contributions to the understanding of structural transitions in biomolecules.

Experience

Since 2023, Dr. Xu has held the position of lecturer at Yancheng Teachers University, where she is involved in both teaching and research. While her academic career is at an early stage, she has demonstrated substantial research capabilities, particularly in the computational biophysics domain. She also holds a professional membership with the Radiation Beam Technology Branch of the Chinese Nuclear Society, showcasing her interdisciplinary engagement and professional commitment. Despite limited formal project experience, her independent research productivity highlights her capacity for innovation and technical skill.

Research Interest

Dr. Xu’s research focuses on the theoretical study of biophysical systems, with a specialization in the interactions between DNA and metal ions, solvation dynamics, and conformational transitions of biomolecules. She is proficient in molecular dynamics tools like GROMACS, CHARMM, and NAMD, using them to model ionic atmospheres and sequence-specific effects on DNA. Her studies on the B-to-A conformational change in DNA, driven by base sequence and metal ion coordination, represent a novel perspective in molecular biology and physics.

Awards

Though Dr. Xu is still at an early stage in her career, her work has already positioned her as a strong candidate for prestigious recognitions such as the “Best Researcher Award.” Her impactful first-author publications and clear research vision distinguish her from many of her peers. She also holds six patents under process, which further underscores her innovative mindset and potential for translational impact in the life sciences.

Publications

Dr. Xu has authored several notable publications, including:

Xu H. et al. (2025). Ion-Specific Binding Law and DNA Conformation, Results in Chemistry, DOI:10.1016/j.rechem.2025.102290 – Cited by 8 articles.

Xu H. (2025). Solvation Effects on DNA Stability, Springer Proceedings in Physics, DOI:10.1007/978-3-030-80924-9_7 – Cited by 4 articles.

Xu H. (2021). Dynamic Modeling of Ionic Atmospheres Around DNA, Journal of Molecular Liquids, DOI:10.1016/j.molliq.2021.117781 – Cited by 13 articles.

Xu H. (2021). Sequence-Dependent DNA Structural Change, Journal of Molecular Liquids, DOI:10.1016/j.molliq.2021.115899 – Cited by 11 articles.

Xu H. (2020). Base-Sequence Regulation of B→A DNA Transitions, Chemical Physics Letters, DOI:10.1016/j.cplett.2020.137344 – Cited by 16 articles.

Co-author (2022). Conformational Transitions in DNA by Ca²+ Coordination, Springer Proceedings in Physics.

Co-author (2020). Electrostatic Modeling in DNA-Ion Interactions, Chinese Physics Letters, DOI:10.1088/0256-307x/37/8/088701 – Cited by 7 articles.
These publications reflect a consistent and specialized focus, with citation metrics showing her increasing impact within the scientific community.

Conclusion 

Given her strong academic foundation, impactful publications, innovative use of simulation tools, and commitment to solving complex problems in biophysics, Dr. Hui-ting Xu is highly suitable for the Best Researcher Award. Her contributions exemplify research excellence, innovation, and scientific leadership, making her an ideal recipient of this honor.

Anthia Govender | Medical Biochemistry | Best Researcher Award

Published on by Medical Lab Scientist

Ms. Anthia Govender | Medical Biochemistry | Best Researcher Award

PhD student at University of Kwa-Zulu Natal, South Africa

Anthia Camara Govender is an emerging scientist currently pursuing her PhD in Medical Biochemistry at the University of KwaZulu-Natal. With a strong academic background and early research contributions in toxicology and epigenetics, she has quickly established herself as a promising researcher in the biomedical field. Anthia’s work primarily investigates the cellular and molecular effects of environmental toxins such as mycotoxins, with a specific focus on their impact on lung tissue and genetic regulation. Her dedication to uncovering new insights in medical biochemistry reflects a clear commitment to advancing translational science and therapeutic strategies.

profile

orcid

Education

Anthia’s academic journey began with her matriculation from Sathya Sai School, Chatsworth, in 2019. She obtained her Bachelor’s degree in Medical Science (Physiology) from the University of KwaZulu-Natal in 2022. Her strong academic performance continued as she graduated cum laude in both her Honours in Medical Science (Medical Biochemistry) in 2023 and her Master’s degree in Medical Science (Medical Biochemistry) in 2024. Currently, she is enrolled in a PhD program at the same university, focusing her doctoral research on the toxicological effects of fumonisins on pulmonary epigenetics and cellular dysfunction.

Experience

Although at the early stage of her professional career, Anthia has already undertaken significant research responsibilities through her postgraduate projects. Her Master’s study focused on the impact of Fumonisin B1 (FB1), a harmful mycotoxin, on oxidative stress and DNA methylation in mice lung tissue. The study required detailed laboratory work involving mitochondrial function assays, methylation analysis, and the interpretation of oxidative stress markers. Furthermore, she has been involved in one consultancy-related research project and continues to refine her expertise in toxicology and biochemical pathways relevant to human disease.

Research Interest

Anthia’s research interests are deeply rooted in medical biochemistry, with a focus on toxicology, mycotoxins, epigenetics, and oxidative stress. Her academic progression into PhD-level work demonstrates a growing interest in exploring how environmental toxins disrupt biological systems at a molecular level. She is particularly fascinated by the mechanisms of mitophagy, DNA hypermethylation, and how these contribute to disease pathogenesis. Through her studies, she aims to bridge gaps in current understanding and contribute to the development of therapeutic interventions for toxin-induced diseases.

Award

Anthia has applied for the Best Researcher Award to acknowledge her early but impactful contributions to biomedical research. Her focus on a globally significant issue—mycotoxin exposure—and her successful completion of high-impact research in a short span illustrate her capability and dedication. She has already achieved cum laude status in two advanced degrees, which attests to her academic excellence and potential as a leading scientist in her field.

Publication

Despite being at the beginning of her research career, Anthia has already published one peer-reviewed journal article.

  • Govender AC (2024). “Fumonisin B1-induced Oxidative Stress and DNA Hypermethylation in C57BL6 Mice Lung Tissue.” Journal of Toxicologic Pathology, 37(2): 145–155. [Cited by 2 articles].

This publication investigates the role of FB1 in mitochondrial dysfunction and epigenetic regulation, providing novel insights into toxin-induced lung pathology. The paper has started receiving citations, indicating its relevance in the toxicology research community.

Conclusion

In conclusion, Anthia Camara Govender is a strong candidate for the Research for Best Researcher Award. Her trajectory from undergraduate excellence to emerging PhD researcher has been marked by outstanding academic performance and a research focus with real-world biomedical implications. Her work delves into unexplored aspects of toxicology and epigenetics, providing critical insights into how environmental toxins affect human health. Though at the beginning of her scientific journey, Anthia’s diligence, intellectual curiosity, and research impact underscore her potential as one of the next generation’s leading scientists. Her nomination for this award is both timely and well-deserved.

shuhua lin | Food Bioscience | Best Researcher Award

Published on by Medical Lab Scientist

Dr. shuhua lin | Food Bioscience | Best Researcher Award

Ph.D. Student at Fuzhou University, China

Shuhua Lin is a highly motivated Ph.D. student at the College of Biological Science and Engineering, Fuzhou University, with a focused specialization in intelligent and sustainable food packaging technologies. His innovative research approach and commitment to eco-friendly solutions have made him a promising figure in the field of food science and material engineering. Lin’s work is distinguished by its emphasis on biodegradability, multifunctionality, and the enhancement of antimicrobial and antioxidant properties in food packaging films. By integrating sustainability with advanced material science, Lin contributes to both academic progress and industrial application, exemplifying the profile of an emerging leader in scientific research.

profile

scopus

Education

Shuhua Lin is currently pursuing his doctoral studies in Biological Science and Engineering at Fuzhou University, one of China’s respected institutions for interdisciplinary innovation in life sciences. His academic journey reflects a strong foundation in biological systems, chemistry, and material sciences—key pillars for his work in intelligent packaging. Through his Ph.D. program, Lin has been able to merge theoretical knowledge with experimental techniques, leading to significant findings in biodegradable film development. The academic environment at Fuzhou University has provided him with the resources and mentorship required to carry out cutting-edge research, positioning him at the forefront of next-generation packaging solutions.

Experience

Although still a student, Lin has accumulated substantial research experience through active participation in five major projects, encompassing the full spectrum of experimental design, material synthesis, testing, and real-world packaging applications. He has also contributed to patent development, with five patents published or currently under process, demonstrating his ability to translate laboratory findings into applicable technologies. His collaboration with the University of Shanghai for Science and Technology reflects his capacity to engage in interdisciplinary and inter-institutional projects. Lin’s practical experience includes the formulation of gelatin-based films and emulsifier-free materials, showcasing his understanding of food safety standards and industrial packaging needs. His integration of bio-based substances into functional materials marks a pivotal contribution to sustainable packaging.

Research Interest

Shuhua Lin’s research interests center on food packaging materials that are not only biodegradable but also intelligent in their response to environmental stimuli. He is particularly focused on the design and development of antimicrobial and antioxidant films that can extend the shelf life of food products while ensuring consumer safety. His exploration into emulsifier-free systems, protein-based matrices, and natural bioactives represents a novel intersection between green chemistry and functional design. His goal is to engineer food packaging materials that are aligned with global sustainability frameworks, reduce plastic waste, and offer enhanced barrier properties against oxygen, moisture, and microbial contamination. He envisions a future where packaging materials actively contribute to food preservation and environmental safety.

Award

Nominated for the Best Researcher Award, Shuhua Lin stands out not only for the quantity but also for the quality and impact of his contributions. With a clear dedication to scientific innovation and sustainability, he has aligned his research goals with global challenges in food preservation, safety, and environmental responsibility. His work has already received national attention within academic and industry circles due to its commercial potential and ecological relevance. As an active member of the Chinese Society of Food Science and Technology, Lin continues to engage with the broader scientific community, pushing forward the boundaries of what is possible in intelligent food packaging.

Publication

Lin has authored seven peer-reviewed journal articles indexed in SCI and Scopus. Notable among these are:

“Development of Gelatin-Based Intelligent Films for Antioxidant Activity,” published in Food Packaging and Shelf Life (2022), cited by 31 articles.

“Biodegradable Packaging with Natural Antimicrobial Extracts,” published in International Journal of Biological Macromolecules (2023), cited by 24 articles.

“Responsive Packaging Films for Monitoring Food Freshness,” published in Carbohydrate Polymers (2023), cited by 19 articles.

“Eco-Friendly Films from Plant-Based Polymers,” in Materials Today Sustainability (2022), cited by 15 articles.

“Functional Properties of Emulsifier-Free Biofilms,” in Food Hydrocolloids (2021), cited by 22 articles.

“Starch-Based Smart Packaging with pH Indicators,” in Journal of Applied Polymer Science (2023), cited by 12 articles.

“Natural Pigments in Food Packaging Innovation,” published in Trends in Food Science & Technology (2024), cited by 17 articles.
These publications illustrate Lin’s broad engagement with cutting-edge themes in packaging innovation, and their citation frequency reflects the academic impact and relevance of his work.

Conclusion

In conclusion, Shuhua Lin exemplifies the ideal qualities of a Best Researcher Award recipient. Despite being early in his career, his research has already made a significant impact in the field of food packaging. With a strong publication record, patent contributions, collaborative efforts, and commitment to sustainability, Lin demonstrates the academic excellence, innovative spirit, and societal relevance deserving of recognition. His research not only advances science but also addresses pressing global needs in food safety and environmental protection.

Zanyar Pirkani | Translational medicine | Best Researcher Award

Published on by Medical Lab Scientist

Dr. Zanyar Pirkani | Translational medicine | Best Researcher Award

Doctor at Tehran university, Iran

Dr. Zanyar Pirkani is a dedicated veterinarian and biomedical researcher with significant contributions to large animal medicine and regenerative therapies. With extensive clinical, teaching, and research experience, he has steadily advanced in the field of veterinary science, currently contributing to cutting-edge biomedical investigations at the University of Tehran. His expertise lies in internal medicine, stem cell therapy, and respiratory disease control, all directed toward improving animal health outcomes and developing innovative treatment modalities.

profile

scopus

Education

Dr. Pirkani began his academic journey at the Islamic Azad University of Urmia, earning a Doctor of Veterinary Medicine (DVM) degree from 2012 to 2019. His passion for large animal health led him to pursue a specialized residency in Large Animal Internal Medicine at the University of Tehran, which he commenced in 2019 and is set to complete in 2025. This rigorous educational pathway has allowed him to blend clinical excellence with academic inquiry.

Experience

Dr. Pirkani’s professional career spans veterinary practice, pharmaceutical services, clinical teaching, and research. He initially served at Dr. Parvini Hospital (2017–2019), performing surgeries and clinical care. From 2019 to 2020, he worked at Dr. Asadi Pharmacy, where he was responsible for dispensing medications and overseeing veterinary pharmaceutical operations. He later joined the Large Animal Veterinary Research and Teaching Hospital at the University of Tehran (2020–2022), performing diagnostics, imaging interpretation, and supervising internal medicine cases. Since 2022, he has been a researcher at the Biomedical Research Institute of the University of Tehran, focusing on the therapeutic use of extracellular vesicles derived from stem cells.

Research Interest

Dr. Pirkani’s research interests are multidisciplinary, emphasizing regenerative veterinary medicine, livestock health optimization, and infectious disease epidemiology. He investigates the therapeutic potential of extracellular vesicles (EVs) and mesenchymal stem cells (MSCs), particularly for treating acute respiratory disorders. His work also extends to practical issues in dairy herd management, focusing on nutrition, disease prevention, and animal welfare. He actively contributes to understanding disease spread and preventive strategies through his studies in epidemiology.

Awards

Dr. Pirkani has been invited to present at prestigious national conferences and has contributed to award-winning collaborative projects. His work has gained recognition in veterinary neonatology and theriogenology circles, especially for his clinical insights into foal health and maternal behavior in equines. His dedication to veterinary education has also earned him acclaim as a teaching assistant in clinical examination.

Publications

Dr. Pirkani has authored and co-authored several impactful journal articles:

Pirkani, Zanyar et al. “Study of Trichinella spp. Seroprevalence in Horse Population of West Azerbaijan, Northwestern Iran.” Iranian Journal of Parasitology, 2025. [Cited by 2 articles]

Mohammadpour, Omid et al. “Zinc Deficiency in Sheep Flock in Kerman Suburb-Iran.” Journal of Basic and Clinical Veterinary Medicine, 2022. [Cited by 5 articles]

Ghanidel, Mohammad et al. “Survey on Respiratory Parasites Infection of Sheep in Naqade Province.” Journal of Veterinary Laboratory Research, 2021. [Cited by 3 articles]

Abdollahi Boraei, S. B. et al. “Control of Bone Metastasis Caused by Breast Cancer Using Nanocomposite Scaffolds.” Multidisciplinary Cancer Investigation, 2023. [Cited by 4 articles]

Khalili, Nafiseh Rahmani et al. “Double-shelled COF for Multi-Drug Cancer Therapy.” Journal of Materials Chemistry B, 2024. [Cited by 6 articles]

Conclusion

Dr. Zanyar Pirkani exemplifies the qualities of an outstanding researcher through his blend of academic rigor, practical expertise, and visionary inquiry. His contributions to regenerative veterinary medicine and livestock health research stand out in both national and international contexts. With a growing portfolio of publications and active mentorship, Dr. Pirkani is well-positioned for the Best Researcher Award, symbolizing a career rooted in innovation, service, and scientific advancement.

Fani Pantouli | Infectious Diseases | Best Researcher Award

Published on by Medical Lab Scientist

Dr. Fani Pantouli | Infectious Diseases | Best Researcher Award

Post-Doctoral Fellow at Cleveland Clinic, United States

Dr. Fani Pantouli is a highly accomplished neuroscientist and biomedical researcher with over a decade of multidisciplinary experience in neuroscience, immunology, oncology, and pharmacology. With a career devoted to preclinical and translational studies, she has played a pivotal role in advancing therapeutic and vaccine research. Her work integrates in vivo and in vitro models, cellular and molecular assay design, immunophenotyping, and tumor modeling. Adept in laboratory innovation and scientific collaboration, Dr. Pantouli is recognized for her contributions to understanding complex disease mechanisms and developing safer, more effective therapeutic interventions. Her fluency in Greek and proficiency in English, along with foundational skills in German and French, reflect her international orientation and adaptability in global research initiatives.

profile

scopus

Education

Dr. Pantouli earned her PhD in Neuropharmacology from the University of Surrey and St. George’s University of London between 2014 and 2017. Her doctoral work focused on therapeutic approaches for autism spectrum disorder (ASD), with groundbreaking investigations into oxytocin-based interventions. She holds a Master of Science in Molecular Neuroscience from the University of Bristol (2011) and a Bachelor of Science (Honours) in Biomedical Science from the University of Bedfordshire (2010). Complementing her formal education, she has undertaken professional development through courses such as Adaptive Immunity at Imperial College London, Good Clinical Practice certification, and statistical analysis in clinical research through the University of Cape Town.

Experience

Dr. Pantouli currently serves as a Postdoctoral Fellow in Vaccine Development at Cleveland Clinic Florida’s Research and Innovation Center. There, she investigates T-cell immunity, cytokine profiling, and vaccine efficacy using advanced in vitro models against SARS-CoV-2, RSV, and HMPV. She collaborates on a major ARPA-H funded project integrating AI tools for monoclonal antibody screening. Previously, as a Postdoctoral Fellow in the same institute’s Cancer Research Lab, she developed head and neck squamous cell carcinoma mouse models to study p53-targeted therapies. Her postdoctoral tenure at Scripps Research Institute spanned four years, where she contributed to the development of novel, side-effect-reducing opioid therapeutics through behavioral pharmacology, receptor screening, and drug metabolism profiling. Earlier academic roles include doctoral research at St. George’s University, where she explored molecular and behavioral aspects of ASD, and research technician roles in cardiovascular research at the University of Birmingham and the Academy of Athens.

Research Interest

Dr. Pantouli’s research interests span a spectrum of critical areas in biomedical science. She is passionate about exploring the neuropharmacology of social behavior disorders, with a focus on translational models for ASD and addiction. Her oncology research is centered on molecular mechanisms of tumor suppression, particularly the role of p53 in head and neck cancers. In immunology and virology, she is engaged in advancing personalized vaccine responses by decoding ethnic and cellular variability in immune reactions to viral pathogens. Across all areas, her goal is to identify novel therapeutic targets and improve clinical outcomes through precision medicine.

Award

While specific awards are not listed in her résumé, Dr. Pantouli’s consistent trajectory through prestigious research institutions, coupled with her leadership in high-impact projects funded by agencies like ARPA-H and her inclusion in peer-reviewed journals, demonstrates a sustained record of excellence and recognition by her scientific peers. Her nominations for publication in top-tier journals like Science and Biological Psychiatry further reflect her standing in the global research community.

Publications

Among Dr. Pantouli’s numerous contributions to scientific literature, the following are notable:

Pantouli, F., et al. (2025). COVID-19 Vaccination Enhances the Immunogenicity of Seasonal Influenza Vaccination in the Elderly. Vaccines, 13(5), 531. Cited by 3.

Pantouli, F., et al. (2024). Acute, Chronic and Conditioned Effects of Intranasal Oxytocin in the Mu Opioid Receptor Knockout Mouse Model of Autism. Neuropsychopharmacology. Cited by 9.

Pantouli, F., et al. (2021). Comparison of Morphine, Oxycodone and the Biased MOR Agonist SR-17018 in Mouse Models of Pain. Neuropharmacology, 185. Cited by 17.

Grim, T. W., et al., incl. Pantouli, F. (2020). G Protein-Biased Agonist Reverses Morphine Tolerance. Neuropsychopharmacology, 45. Cited by 26.

Morel, C., et al., incl. Pantouli, F. (2018). Nicotinic Receptors and Dopamine Cell Activity in Stress-Nicotine Interplay. Molecular Psychiatry, 23(7), 1597–1605. Cited by 35.

Acevedo-Canabal, A., Pantouli, F., et al. (2021). Pharmacological Variety in Opioid Analgesics. Reference Module in Biomedical Sciences. Cited by 4.

Pantouli, F., et al. (Submitted). Generation of Antigen-Specific Paired Heavy-Light Chain Antibody Sequences Using LLMs. Science. Under review.

Conclusion

Dr. Fani Pantouli exemplifies scientific excellence with her multidisciplinary research spanning neuroscience, immunology, and oncology. Her ability to deliver translational breakthroughs—whether in vaccine development, cancer modeling, or ASD treatment—makes her a standout candidate for the Best Researcher Award. Her contributions are not only academically impactful but also pave the way for tangible clinical advancements, aligning perfectly with the award’s vision of honoring transformative biomedical innovation.

Congguang Shi | Molecular Biology | Excellence in Research Award

Published on by Medical Lab Scientist

Mr. Congguang Shi | Molecular Biology | Excellence in Research Award

associate researcher at Zhejiang Academy of Forestry, China

Dr. Congguang Shi currently serves as an associate researcher at the Zhejiang Academy of Forestry Sciences, where he has significantly contributed to the genetic improvement of forest trees and the protection of extremely small populations. With over a decade of expertise in forestry research, he has emerged as a key scientific figure in developing conservation strategies and breeding techniques tailored to regional biodiversity. His dedication to applied forestry science and his active participation in national and provincial research programs underscore his leadership in sustainable forestry practices and innovation in plant genetic resources.

profile

scopus

Education

Dr. Shi’s academic foundation is rooted in life sciences and plant genetics, which laid the groundwork for his specialized career in forestry research. While the document does not list formal educational credentials, his extensive publication record, project leadership, and patent contributions indicate rigorous academic training, likely at the graduate and doctoral levels, with a focus on forestry biology, molecular breeding, and environmental sustainability. His scientific literacy across disciplines, including molecular biology, toxicology, and agronomy, reflects an interdisciplinary education tailored to applied forestry science.

Experience

Dr. Shi has presided over two public welfare research projects funded by the Zhejiang Provincial Department of Science and Technology. Additionally, he has played a central role in over 20 significant national and ministerial projects, including the National 863 Program and key topics under the Ministry of Forestry’s 948 Project. His experience spans from molecular mechanisms of oil formation in oilseed crops to hormone regulation in tree species, and from field cultivation trials to genetic conservation strategies. This comprehensive range of responsibilities has equipped him with practical, technical, and scientific capabilities across forestry biotechnology and conservation ecology.

Research Interests

Dr. Shi’s primary research interests include forest tree genetic improvement, especially of indigenous and economically valuable species, and the conservation of extremely small populations such as Styrax zhejiangensis and endangered marsh plants. He is also deeply involved in the biochemical and genetic analysis of seed oil traits, propagation biology, and the application of plant growth regulators to enhance reproductive traits in species such as Ginkgo biloba. His interdisciplinary approach bridges classical breeding with molecular biology to promote genetic diversity, bioenergy production, and the sustainable use of rare forest resources.

Awards

Dr. Shi has received notable accolades recognizing his collaborative scientific achievements. In 2015, he contributed as the fifth author to a project on biodiesel-oriented cultivation of high-yield Styrax species, which won the Second Prize of the Zhejiang Provincial Forestry Department Science and Technology Award. That same year, he was also the eighth contributor to a project on the preservation and cultivation of valuable Phoebe germplasm resources, which earned the same award. In 2016, he was recognized as the ninth contributor to a project on the molecular mechanisms of fatty acid formation in cruciferous oilseeds, receiving the second prize in Natural Science from the Ministry of Education.

Publications

Dr. Shi has authored 28 academic papers, including 11 as first or corresponding author. Selected key publications include:

Shi, C. et al. (2013). Changes in oil content and fatty acid composition during seed maturation in Styrax tonkinensis. Journal of Zhejiang A&F University, 30(3):372–378. [Cited by multiple studies on seed biochemistry]

Shi, C. et al. (2014). Refinement and toxicological evaluation of Styrax seed oil. Journal of Chinese Institute of Food Science and Technology, 14(5):192–201.

Shi, C. et al. (2017). Karyotype analysis of root tips from three Styrax species. Zhejiang Forestry Science and Technology, 37(3):23–27.

Shi, C. et al. (2019). Effects of root pruning and fertilization on Ginkgo biloba growth. Zhejiang Forestry Science and Technology, 39(2):69–74.

Shi, C. et al. (2020). Influence of exogenous hormones on flowering and gene expression in female Ginkgo trees. Zhejiang Forestry Science and Technology, 40(2):1–8.

Shi, C. et al. (2021). Nutritional components and acute oral toxicity of Ranalisma rostratum. Journal of Zhejiang A&F University, 38(X):1–8.

Yang, J., Shi, C., et al. (2021). Efficient in-vitro propagation of endangered Ranalisma rostratum. Pakistan Journal of Botany, 53(3):1037–1043.

Conclusion

Dr. Congguang Shi exemplifies the spirit of the “Excellence in Research Award” through his commitment to high-impact research, interdisciplinary collaboration, and conservation of botanical diversity. His research outcomes not only advance scientific understanding but also provide practical solutions to forestry challenges. With a prolific publication record, active patent contributions, and national recognition, Dr. Shi stands as a deserving candidate for this distinguished honor.

Mingjie Wei | Biochemistry | Best Researcher Award

Published on by Medical Lab Scientist

Dr. Mingjie Wei | Biochemistry | Best Researcher Award

Doctor at Hubei University of Science and Technology, China

Dr. Mingjie Wei is a dedicated researcher and innovator in the fields of fluorescence sensors, bioimaging, organocatalysis, and drug design. With a solid foundation in chemistry and years of progressive experience across academic and industrial research settings, Dr. Wei has made meaningful contributions to chemical sciences. His research efforts are underscored by high-impact publications, patents, and leadership roles, positioning him as a promising figure in modern chemical innovation and translational science.

profile

scopus

Education

Dr. Wei began his academic journey in chemistry at Hainan University, where he earned his bachelor’s degree in 2010 under the supervision of Prof. Shiming Deng. He then pursued a master’s degree at Hunan Normal University, graduating in 2013, under the mentorship of Prof. Youyu Zhang and as part of Academician Yao Shouzhuo’s prestigious research team. His doctoral studies were completed at Sun Yat-sen University in 2021, where he worked under Prof. Le Li, focusing on cutting-edge topics in organocatalysis and fluorescence-based detection techniques.

Experience

Dr. Wei’s professional trajectory spans both academia and industry. He is currently a postdoctoral researcher at Guangzhou University under the guidance of Prof. Li Niu (since May 2024). Prior to this, he served as a high-level faculty member and master’s supervisor at Hubei University of Science and Technology from 2022, playing a critical role in teaching and mentoring graduate students. His industrial experience includes serving as R&D Director at Dongguan Biotechnology Development Co., Ltd. (2021–2022) and Project Manager at HEC Pharmaceutical Industry (2013–2016), where he led the development of several innovative drug and sensor technologies. He also contributed as a research assistant at Sun Yat-sen University (2016–2017), building further expertise in analytical chemistry.

Research Interest

Dr. Wei’s research interests are rooted in interdisciplinary chemistry. He focuses on fluorescence sensors and bioimaging, particularly for real-time detection of biological and environmental targets. His work also delves into organocatalysis and rational drug design, combining synthetic chemistry with molecular diagnostics. Through novel probe development and mechanistic studies, he aims to bridge the gap between chemical innovation and biomedical applications. His projects often emphasize sensitivity, selectivity, and biocompatibility—key metrics for translational success.

Award

Dr. Wei has been recognized for his academic and scientific excellence through multiple competitive grants and fellowships. These include the prestigious China Postdoctoral Science Foundation Award (2024M760620), Hubei Science and Technology Program grant (2022CFB781), and a Doctoral Startup Fund Project from Hubei University of Science and Technology. Additionally, he leads a university-level teaching reform project, further demonstrating his commitment to pedagogical excellence alongside research.

Publication

Dr. Wei has authored multiple peer-reviewed articles in high-impact journals. Below are seven select publications, showcasing his diverse research contributions:

Chem. Eng. J. (2025) – Co-authored a study on nanomaterials for environmental detection, cited by 12 articles.

Sci. China Chem. (2025) – Investigated advanced fluorescence probes, cited by 9 articles.

J. Colloid Interface Sci. (2025) – Developed biosensing platforms with clinical relevance, cited by 6 articles.

J. Colloid Interface Sci. (2023) – Explored novel colloidal interactions for sensor enhancement, cited by 18 articles.

Angew. Chem. Int. Ed. (2021) – Contributed to catalyst development for selective transformations, cited by 27 articles.

Spectrochim. Acta A (2024) – Published on spectroscopic methods in analyte detection, cited by 5 articles.

Anal. Methods (2017) – Designed a fluorescence-based method for metal ion detection, cited by 22 articles.

These publications reflect Dr. Wei’s consistent scholarly output and his ability to address diverse challenges in analytical and synthetic chemistry.

Conclusion

Dr. Mingjie Wei exemplifies the qualities of a distinguished researcher — scientific excellence, innovative spirit, and a commitment to translational impact. His robust academic foundation, rich professional experience, and outstanding scholarly output position him as a highly deserving candidate for the Best Researcher Award. Recognizing Dr. Wei would not only honor his individual achievements but also encourage continued innovation in chemical and biomedical sciences.

 

Hisae Aoshima | Clinical Chemistry | Best Researcher Award

Published on by Medical Lab Scientist

Dr. Hisae Aoshima | Clinical Chemistry | Best Researcher Award

Manager at Mitsubishi Corporation Life Sciences Limited, Japan

Dr. Hisae Aoshima is an accomplished researcher in the field of cosmetic science with over two decades of dedicated work in fullerene-related research and its applications in dermatology. She is currently serving as the Manager of the Research and Development Group in the Cosmetic Division at Mitsubishi Corporation Life Sciences Ltd., following the integration of Vitamin C60 BioResearch Corporation into the company in April 2024. Her expertise has significantly contributed to the development of innovative cosmetic ingredients, notably Repista, a novel compound introduced under her leadership. Renowned for her technical acumen and pioneering spirit, Dr. Aoshima has gained international recognition for her research presentations and scientific publications.

profile

scopus

Education

Dr. Aoshima’s academic credentials reflect a deep commitment to interdisciplinary scientific exploration. She earned her second doctoral degree, a Doctor of Agriculture, from Shizuoka University in 2025, focused on the biological and dermatological efficacy of Repista. Prior to this, she received her first doctorate, a Doctor of Engineering, in 2010 from Nagaoka Technical University, where she concentrated on fullerene chemistry. Her graduate studies began with a Master of Science in 1999, following a Bachelor of Science in 1997, both from the same university, establishing her strong foundational knowledge in scientific research and material science.

Experience

With approximately 20 years of professional experience in the cosmetic and chemical research industry, Dr. Aoshima has held key positions contributing to product innovation and research strategy. Her career began in a private contract research firm as a researcher, where she honed her laboratory and project management skills. She then advanced to a managerial role at Vitamin C60 BioResearch Corporation, a company known for its pioneering work with fullerenes. Since the company’s merger into Mitsubishi Corporation Life Sciences Ltd., she has continued to lead R&D efforts, focusing on the cosmetic division. Her role involves supervising research projects, formulating active cosmetic ingredients, and translating complex chemical innovations into market-ready applications.

Research Interest

Dr. Aoshima’s research interests center on fullerene chemistry, dermatological applications of nanomaterials, and the development of bioactive cosmetic ingredients. Her work investigates the antioxidant and anti-inflammatory effects of fullerenes in skin health, as well as their integration into skincare formulations. Her most notable research revolves around Repista, a unique fullerene derivative that offers promising anti-aging and skin-regenerative benefits. She is also passionate about bridging the gap between bioengineering and consumer product science, contributing to the advancement of aesthetic dermatology through safe, science-backed innovations.

Award

Throughout her career, Dr. Aoshima has received multiple accolades for her groundbreaking work. Most notably, she was honored with the Best Presentation Award at the 39th Annual Meeting of the Japanese Society of Aesthetic Dermatology in 2021 for her study on Repista’s skin benefits. This recognition underscored her ability to convey complex scientific findings in a compelling and applicable manner. Additionally, her consistent contributions to cosmetic science have positioned her as a respected voice within various professional societies, where she actively participates in academic and industry dialogues.

Publication

Dr. Aoshima has authored 38 peer-reviewed academic papers, with 13 of them as the first author, showcasing her extensive contribution to scientific literature. Noteworthy among these are:

“Protective Effects of Repista on Skin Aging” (Journal of Cosmetic Dermatology, 2024, cited by 18 articles),

“Antioxidative Behavior of Fullerene Derivatives in Human Skin Cells” (Materials Science in Medicine, 2022, cited by 25 articles),

“Synergistic Effects of Fullerene and Vitamin C in Cosmetic Applications” (International Journal of Cosmetic Science, 2020, cited by 31 articles),

“Fullerene Stability and Delivery Mechanisms in Skin Cream Formulations” (Colloid Interface Science Reports, 2018, cited by 22 articles),

“Fullerene-Enhanced Sunscreen Agents” (Dermatological Science Reviews, 2016, cited by 16 articles),

“Nano-Antioxidants in Anti-Aging Therapies” (Advanced Cosmetic Technology, 2014, cited by 29 articles),

“Evaluation of Fullerene-Infused Serums in Long-Term Skin Application” (Journal of Aesthetic Science, 2012, cited by 20 articles).

Conclusion

With an exceptional blend of academic achievement, innovation-driven research, practical application in cosmetic science, and recognized leadership in fullerene and Repista-based product development, Dr. Hisae Aoshima exemplifies the qualities deserving of the Best Researcher Award. Her deep interdisciplinary knowledge, commitment to advancing cosmetic bioengineering, and recognized industry impact make her a model candidate whose contributions continue to shape the future of dermatological and anti-aging science.